FEDL yields 3.59% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, FEDL + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FEDL + JNJ for your $10,000?
FEDL provides 2x leveraged exposure to the compounded quarterly performance of an index that invests in large-cap US securities that the issuer believes is best positioned to benefit from the current monetary landscape. The index will use a proprietary methodology to classify the prevailing monetary environment as expansive, restrictive, or indeterminate. The 500 largest NYSE-listed stocks are then scored by several fundamental metrics, based on their potential to benefit from the current environment, where 75 of the best scoring stocks are selected for inclusion. The selected stocks are also weighted using their score with additional factors like liquidity, individual stock, and sector weights. The index is rebalanced when the prevailing monetary environment changes. Note: As a leveraged ETN, DEFL should only be held as a short-term trading tool and carries the credit risk of the issuer.
Full FEDL Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.